Highlights from Sectra's 2025 Annual General Meeting and Financial Decisions

Overview of Sectra's 2025 Annual General Meeting

On September 9, 2025, Sectra, the renowned international company specializing in medical imaging IT and cybersecurity, convened its Annual General Meeting (AGM) in Linköping, Sweden. This pivotal event brought together shareholders to discuss the company's financial performance and future strategies while voting on several key resolutions proposed by the board.

Dividend Distribution

One of the meeting's highlights was the decision to distribute a total dividend of SEK 2.10 per share, which includes an ordinary dividend of SEK 1.10 and an extra dividend of SEK 1.00. This decision reflects Sectra's strong fiscal health and commitment to returning value to its shareholders. The record date for this dividend is set for September 11, 2025, with anticipated payments scheduled for September 16, 2025, via Euroclear Sweden AB.

Financial Audits and Board of Directors

In addition to the dividend distributions, the AGM endorsed the income statement and balance sheet for the fiscal year 2024/2025. All board members, along with the President and CEO, were discharged from liability for their actions during this fiscal period. The meeting also approved remuneration for board members, with external members receiving SEK 350,000 each and the Chairman earning SEK 700,000, alongside designated amounts for Audit and Remuneration Committee work.

Seven board members, including Jan-Olof Brüer as Chairman, were re-elected to continue their crucial roles in guiding Sectra's strategic objectives. Moreover, Ernst & Young AB was re-elected as the company's auditor, ensuring continued rigorous oversight of Sectra's financial practices.

Future Share Issuances and Treasury Shares

The AGM also authorized the Board to issue up to 18,500,000 new Class B shares for various purposes, including cash payments, debt offsetting, or non-cash contributions. This move aims to support potential acquisitions and market investments, which could further strengthen Sectra's position within the medical imaging sector. Importantly, the board was also granted approval to manage the acquisition and divestment of the company’s treasury shares, ensuring the total does not exceed 10% of all outstanding shares.

Conclusion

The 2025 AGM underscored Sectra's dedication to its shareholders and its proactive approach to financial and operational governance. By prioritizing dividend distributions and reinforcing board leadership, Sectra set a robust foundation for future growth and investment strategies. The meeting's decisions are pivotal as the company continues to expand its footprint in the healthcare technology landscape, navigating challenges while leveraging opportunities for advancement.

For more information, visit Sectra's investor relations.